Biologic Drugs for the Treatment of Hidradenitis Suppurativa: An Evidence-Based Review

被引：16

作者：

Shuja, Fareesa ^{[1
]}

Chan, C. Stanley ^{[1
]}

Rosen, Ted ^{[1
]}

机构：

[1] Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA

来源：

DERMATOLOGIC CLINICS | 2010年 / 28卷 / 03期

关键词：

Hidradenitis suppurativa; Biologics; Nodules; Abscesses; LONG-TERM EFFICACY; CROHNS-DISEASE; ACNE INVERSA; INFLIXIMAB; ETANERCEPT; ADALIMUMAB; THERAPY; MANAGEMENT; EFALIZUMAB; ARTHRITIS;

D O I：

10.1016/j.det.2010.03.012

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

There are various treatment options for hidradenitis suppurativa (HS), a recurrent and suppurative disease, but none is wholly satisfactory or effective. There have been many reports on the efficacy of biologic drugs for the treatment of HS; this article is an in-depth review of the published evidence on this topic. Because the current evidence is limited, randomized, double-blinded, placebo-controlled trials are needed to better elucidate the future of these drugs for the treatment of HS.

引用

页码：511 / +

页数：15

共 50 条

[1] Evidence-based approach to the treatment of hidradenitis suppurativa based on the European Guidelines for hidradenitis suppurativa
Gulliver, Wayne
Tzellos, Thrasivoulos
Zouboulis, Christos C.
Jemec, Gregor B. E.
Prens, Errol
[J]. EXPERIMENTAL DERMATOLOGY, 2016, 25 : 9 - 9
[2] Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
Gulliver, Wayne
Zouboulis, Christos C.
Prens, Errol
Jemec, Gregor B. E.
Tzellos, Thrasivoulos
[J]. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2016, 17 (03): : 343 - 351
[3] Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
Wayne Gulliver
Christos C. Zouboulis
Errol Prens
Gregor B. E. Jemec
Thrasivoulos Tzellos
[J]. Reviews in Endocrine and Metabolic Disorders, 2016, 17 : 343 - 351
[4] Biologic Treatment for Hidradenitis Suppurativa
Kelsey S. Flood
Martina L. Porter
Alexa B. Kimball
[J]. American Journal of Clinical Dermatology, 2019, 20 : 625 - 638
[5] Biologic Treatment for Hidradenitis Suppurativa
Flood, Kelsey S.
Porter, Martina L.
Kimball, Alexa B.
[J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (05) : 625 - 638
[6] Biologic therapies for the treatment of hidradenitis suppurativa
Santillan, Monica
Morss, Peyton C.
Porter, Martina L.
Kimball, Alexa B.
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) : 621 - 633
[7] Treatment of hidradenitis suppurativa with biologic medications
Lee, Robert A.
Eisen, Daniel B.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (05) : S82 - S88
[8] Management of Hidradenitis Suppurativa Using Janus Kinase Inhibitors: An Evidence-Based Review
Sood, Siddhartha
Varenbut, Jaymie
Heung, Martin
Maliyar, Khalad
Sachdeva, Muskaan
Abduelmula, Abrahim
Georgakopoulos, Jorge R.
Mufti, Asfandyar
Yeung, Jensen
[J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2023, 27 (06)
[9] Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
Garg, Amit
Malviya, Neeta
Strunk, Andrew
Wright, Shari
Alavi, Afsaneh
Alhusayen, Raed
Alikhan, Ali
Daveluy, Steven D.
Delorme, Isabelle
Goldfarb, Noah
Gulliver, Wayne
Hamzavi, Iltefat
Jaleel, Tarannum
Kimball, Alexa B.
Kirby, Joslyn S.
Kirchhof, Mark G.
Lester, Janice
Lev-Tov, Hadar
Lowes, Michelle A.
Micheletti, Robert
Orenstein, Lauren A.
Piguet, Vincent
Sayed, Christopher
Tan, Jerry
Naik, Haley B.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (05) : 1092 - 1101
[10] Biologic drugs in hidradenitis suppurativa: what does the GP have to know? A narrative review
Mendes-Bastos, Pedro
Benhadou, Farida
Venturini, Marina
Molina-Levya, Alejandro
Thomas, Nicolas
Alarcon, Ivette
Bechara, Falk G.
[J]. FRONTIERS IN MEDICINE, 2024, 11

← 1 2 3 4 5 →